PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Brinker Capital Investments, LLC's Holding History (CIK: 0001360533)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 4,396 Value ($000) $384 Avg Close $81.85 Range $62.24 - $96.54

Q3 2025

Shares 6,928 Value ($000) $460 Avg Close $56.84 Range $49.38 - $68.26

Q2 2025

Shares 6,600 Value ($000) $365 Avg Close $47.99 Range $39.60 - $57.70

Q1 2025

Shares 6,731 Value ($000) $326 Avg Close $41.90 Range $33.70 - $60.60

Q3 2024

Shares 6,114 Value ($000) $275 Avg Close $40.40 Range $32.50 - $48.00

Q2 2024

Shares 7,388 Value ($000) $256 Avg Close $29.29 Range $24.22 - $35.96

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	4,396	$384	$81.85	$62.24 - $96.54
Q3 2025	6,928	$460	$56.84	$49.38 - $68.26
Q2 2025	6,600	$365	$47.99	$39.60 - $57.70
Q1 2025	6,731	$326	$41.90	$33.70 - $60.60
Q3 2024	6,114	$275	$40.40	$32.50 - $48.00
Q2 2024	7,388	$256	$29.29	$24.22 - $35.96